Marty Makary Out as FDA Commissioner

His resignation comes after speculation over the past week he would be fired by President Trump.

Key Highlights

  • - Marty Makary resigned as FDA commissioner amid policy disagreements over flavored e-cigarettes.
  • - His opposition to fruit-flavored vapes stemmed from concerns about attracting children to vaping products.
  • - The resignation occurred after a week of speculation and internal conflicts within the FDA.
  • - Kyle Diamantas will serve as acting commissioner following Makary's departure.
  • - Makary's tenure was characterized by tensions over COVID vaccine approvals and youth vaping concerns.

Marty Makary has resigned from his post as FDA commissioner. CIDRAP has the news.

The resignation comes after a “week of speculation that he would soon be fired by President Donald Trump.” Kyle Diamantas, the agency’s deputy commissioner for food, will serve as acting commissioner.

According to anonymous sources cited by The New York Times, “Makary resigned over the administration’s decision to authorize fruit-flavored e-cigarettes, an action he opposed, noting that grape-flavored vapes could make the product more attractive to children.”

He both “angered Trump and his supporters” and “promoted the Make America Healthy Again (MAHA) agenda” during his tenure, but he “angered some in the MAHA movement when the FDA approved updated mRNA COVID vaccines.”

About the Author

Matt MacKenzie

Associate Editor

Matt is Associate Editor for Healthcare Purchasing News.

Sign up for our eNewsletters
Get the latest news and updates